No connection

Search Results

HCTI vs TIVC

HCTI
Healthcare Triangle, Inc.
BEARISH
Price
$2.40
Market Cap
$2.8M
Sector
Healthcare
AI Confidence
95%
TIVC
Tivic Health Systems, Inc.
BEARISH
Price
$1.13
Market Cap
$3.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
HCTI
--
TIVC
--
Forward P/E
HCTI
-0.08
TIVC
-0.05
P/B Ratio
HCTI
0.14
TIVC
0.17
P/S Ratio
HCTI
0.21
TIVC
--
EV/EBITDA
HCTI
-1.29
TIVC
0.37

Profitability

Gross Margin
HCTI
13.12%
TIVC
0.0%
Operating Margin
HCTI
-74.26%
TIVC
0.0%
Profit Margin
HCTI
-48.84%
TIVC
0.0%
ROE
HCTI
-183.0%
TIVC
-82.69%
ROA
HCTI
-39.27%
TIVC
-28.69%

Growth

Revenue Growth
HCTI
44.6%
TIVC
--
Earnings Growth
HCTI
--
TIVC
--

Financial Health

Debt/Equity
HCTI
0.18
TIVC
0.38
Current Ratio
HCTI
2.03
TIVC
20.13
Quick Ratio
HCTI
1.94
TIVC
19.57

Dividends

Dividend Yield
HCTI
--
TIVC
--
Payout Ratio
HCTI
0.0%
TIVC
0.0%

AI Verdict

HCTI BEARISH

HCTI presents a classic value trap scenario, characterized by a stable Piotroski F-Score of 4/9 but catastrophic price action and fundamental decay. While the company shows strong top-line revenue growth of 44.6%, it is coupled with a disastrous ROE of -183% and an operating margin of -74.26%. The extreme discrepancy between the 52-week high ($7470) and current price ($2.40) indicates a total collapse in investor confidence or a massive corporate restructuring. Despite low debt and a healthy current ratio, the lack of profitability and negative earnings surprises make this a high-risk speculative asset.

Strengths
Strong YoY revenue growth of 44.60%
Low Debt/Equity ratio of 0.18
Healthy liquidity with a Current Ratio of 2.03
Risks
Catastrophic price performance (-99.9% 1Y change)
Severe negative profitability (Profit Margin -48.84%)
Extreme equity erosion (ROE -183%)
TIVC BEARISH

TIVC exhibits severe financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. Despite a high current ratio suggesting short-term liquidity, the company is experiencing a catastrophic collapse in revenue (-267.78% Q/Q) and a near-total loss of shareholder value over a 5-year horizon (-100%). While the stock trades at a deep discount to book value (P/B 0.17), the lack of profitability and negative ROE (-82.69%) suggest a value trap rather than a value opportunity.

Strengths
Extremely high current ratio (20.13) indicating strong short-term liquidity
Low Debt/Equity ratio (0.38) relative to healthcare sector average
Recent quarterly earnings beats (though still deeply negative)
Risks
Catastrophic Q/Q revenue decline of -267.78%
Severe long-term price erosion (99.5% loss over 3 years)
Critical Piotroski F-Score of 1/9 signaling fundamental failure

Compare Another Pair

HCTI vs TIVC: Head-to-Head Comparison

This page compares Healthcare Triangle, Inc. (HCTI) and Tivic Health Systems, Inc. (TIVC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile